Dissection of Thoracic Aorta Clinical Trial
Acute kidney injury (AKI) is one of the most frequently encountered and prognostically
significant complications after cardiovascular surgery. However, there is no definitive
treatment to intervene after development of AKI, therefore, preventive strategy has been the
major issue. By this time, incidence of AKI after cardiovascular surgery has been reported
3-50% based on the studies with various definition of AKI and different patient cohorts.
Development of unified definition for AKI in the early 2000s opened a new era in AKI study.
According to the previous studies, aortic surgery, especially thoracic aortic surgery was
known to be highly prevalent of AKI, which was considered to be caused by use of total
circulatory arrest (TCA), relatively high number of emergency cases, combined malperfusion
syndrome before surgery and relatively complicated surgical procedure. However, there has
not been many studies of AKI in thoracic aortic surgery because of its low incidence and
urgent clinical presentation of aortic pathology, which hinder large randomized controlled
study. Moreover, there are conflicting reports of incidence and risk factors of AKI after
thoracic aortic surgery, no conclusive result has been made. Therefore, this study was
designed to investigate the incidence and risk factors after thoracic aortic surgery only
due to dissection.
n/a
Observational Model: Cohort, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05639569 -
Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study
|
||
Completed |
NCT01369732 -
Prevention of Acute Kidney Injury by Erythropoietin in Thoracic Aorta Surgery With Hypothermic Cardiac Arrest
|
Phase 4 | |
Active, not recruiting |
NCT05030740 -
French Assessment of the Relay Plus and Relay NBS Plus Thoracic Stent-Graft
|
||
Recruiting |
NCT03322033 -
Feasibility of Endovascular Repair of Ascending Aortic Pathologies
|
N/A |